Rabies Vaccine Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030
Page: 215 | Report Code: LS240108 | Research Suite: Report (PDF) & Market Data (Excel)
The global market value of the Rabies Vaccine market was valued at USD 1.1 billion, and a CAGR of 5.1% is expected during the forecast period. The increase in the prevalence of rabies is driving the growth in the Rabies vaccine market significantly. People who have three doses have less possibility of suffering from rabies. According to a stat, approx. 59,000 people all around the world die every year due to rabies. Most of the cases of rabies occur in the Asia Pacific and Africa. The majority of the cases are found in rural areas, with most of the population suffering from the disease less than 15 years old. Lack of awareness about the disease is driving the growth in the market. Growing awareness among people to early diagnose the bacterial and viral disease is driving the growth in the market.
Impact of
Covid-19
Covid-19 badly hampered the rabies
vaccine market due to supply chain disruption, stringent lockdown conditions,
and social distancing. At the beginning of the pandemic, people were bothered
about the CID-19 pandemic mainly, but later on, when things got normalized, the
rabies vaccine market had again noticed a significant growth due to an
increasing number of cases of rabies. Rabies is a deadly viral disease that
affects mammals, including human beings. The virus is transmitted by the saliva
of the affected animal. The rise in the prevalence of bites is anticipated to
boost the growth in the market significantly. The rise in initiatives taken by
governments, and private organization is boosting the growth in the rabies
market. Covid-19 brought a significant temporary slowdown in the market. Post
CID-19 when everything became normal, people started to take every bacterial
and viral disease seriously.
Growth Drivers
The increasing prevalence of dog bite cases all over the world is driving the growth in this market. Increasing awareness of people all around the world about viral diseases is driving the growth in the market. Increasing government initiatives is another reason behind the growth in this market. However, lack of awareness about rabies in the rural areas is acting as an obstacle. The rise in initiatives by governments for dog vaccination is propelling the growth in the market. initiatives to boost the market growth by providing rabies vaccines at every healthcare centers in excess.
The rising pet population is also boosting the growth in the market. Technological advancements in vaccine production are driving the growth in the rabies vaccine market. Government initiatives, and efforts to control rabies transmission are driving the growth in the market significantly. Expanding vaccination programs in developing countries worldwide is driving the demand for the vaccination. Increasing inclination towards having pets at home is driving the growth in the market. Rising awareness about the animal health, government initiatives for rabies eradication, and advancement in vaccine technologies, is driving the growth in the market significantly.
Segmentation
Vaccine Type
·
Animal Vaccine
·
Human Vaccine
Administration
·
Oral
·
Intramuscular
·
Intradermal
Distribution
Channel
·
Hospital
·
Pharmacies
·
Retail
Pharmacies
·
Online
Pharmacies
Regional
Outlook
·
Asia Pacific
·
North America
·
Europe
·
Latin America
·
Middle East and
Africa
Rabies Vaccine
Market Type Segmentation
On the basis of vaccine type, the rabies vaccine market
is segmented into animal vaccines, and human vaccines. Animal vaccine, and
Human vaccine for rabies serve different purposes but share the common goal of
preventing the spread of rabies virus. Animal vaccines are primarily used for
preventing rabies in domestic animals like dogs, cats, and livestock. Animal
vaccines are usually administered by veterinarians, according to recommended
schedules to protect pets and livestock. It is vital in preventing the
transmission of rabies from animals to humans as most human cases results from
bites, or scratches from infected animals. Human vaccines are used for
pre-exposure or post-exposure prophylaxis in individuals, at risk of rabies
exposure. It is administered to individuals travelling to high risk areas,
certain occupational groups, and individuals potentially exposed to virus. It
is crucial in preventing the development of rabies in individuals following
exposure to virus specially if administered promptly after potential exposure.
Rabies
Vaccination Market Distribution Channel Segmentation
On the basis of distribution channel,
the rabies vaccination market is segmented into hospitals, pharmacies, retail
pharmacies, and online pharmacies. Hospitals are the leading segment, and due
to government awareness, and emphasis on having rabies vaccines at government
hospitals, it is driving the growth in the market. Retail pharmacies are the
second leading segment, and online pharmacies are expected to drive the growth
during the forecast period. Increasing cases of dog bites all over the world is
driving the demand for rabies vaccine in the market.
Regional
Outlook
On the basis of the regions, the rabies vaccine market is segmented into 5 regions: Asia Pacific, North America, Latin America, Europe, and Middle East and Africa. Regions with high incidence of rabies has particularly in demand for more rabies vaccines are leading the market during the forecast period. Efforts in these regions are made to provide the higher demand for the vaccines. Increasing the preventing measures to reduce the rabies cases is also driving the growth in the market. Regions with lower prevalence rates like Europe, and North America are emphasizing on vaccination programs.
In North America Rabies vaccination program is well established for both humans and animals. Vaccination protocols for pets, especially dogs and cats are widely implemented to prevent the spread of rabies. Public health campaigns, and educational efforts, aim to raise awareness about rabies prevention. Most European countries have stringent pet vaccination requirements to control rabies transmission. Human vaccination is also available mainly through post-exposure, prophylaxis following potential exposure to virus. Countries like United States, United Kingdom, Italy, Germany, France, and China are the countries leading in this market. African countries like Ghana, Nigeria, South Africa, are the leading market in rabies vaccination. Increasing number of pets in all over the world is driving the growth in all over the world.
Key Players
·
Sanofi Pasteur
·
GlaxoSmithKline
Plc
·
Pfizer Inc
·
Merck and Co.
·
Boehringer
Ingelheim
·
Zoetis Inc
·
Elanco
·
HDCV
·
Emovax
·
Rabies Vaccine
Human Diploid Cell Culture
· Other Players